Hansa Biopharma AB (HNSAN) Q2 2024 Earnings Report
MX:HNSAN Q2 2024 EPS Results
- Actual EPS
- -MXN 6.31
- Consensus EPS
- -MXN 5.32
- Beat/Miss
- Missed by -MXN 0.99
- One Year Ago EPS
- -MXN 9.16
MX:HNSAN Q2 2024 Revenue Results
- Actual Revenue
- MXN 65.64M
- Expected Revenue
- MXN 103.75M
- Beat/Miss
- Missed by -MXN 38.11M
- YoY Revenue Growth
- -6.32%
Earnings Announcement Details
- Quarter
- Q2 2024
- Date
- 07/18/2024
- Time
- Before Open
- Conference Call
- Thursday, July 18, 2024
MX:HNSAN Upcoming Earnings
Hansa Biopharma AB's next earnings date is estimated for November 11, 2026, based on past reporting schedules.
Q2 2024 Earnings Call Audio
No earnings call audio is available for this earnings event.
Q2 2024 Earnings Slide Deck
No slide deck is available for this earnings event.
Q2 2024 Earnings Call Summary
No earnings call summary is available for this earnings event.
MX:HNSAN Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Nov 11, 2026 | 2026 (Q3) | -2.71- | -3.35 | ― | ― |
| Jul 22, 2026 | 2026 (Q2) | -0.64-4.89 | -4.84 | -1.19% (-0.06) | |
| Apr 23, 2026 | 2026 (Q1) | -2.77-3.69 | -1.05 | -250.91% (-2.64) | |
| Feb 11, 2026 | 2025 (Q4) | -3.01-3.10 | -7.8 | 60.29% (+4.70) | |
| Oct 30, 2025 | 2025 (Q3) | -3.32-3.35 | -2.93 | -14.38% (-0.42) | |
| Jul 17, 2025 | 2025 (Q2) | -3.17-4.84 | -6.31 | 23.33% (+1.47) | |
| Apr 24, 2025 | 2025 (Q1) | -5.11-1.05 | -7.93 | 86.75% (+6.88) | |
| Feb 06, 2025 | 2024 (Q4) | -3.79-7.80 | -4.59 | -70.00% (-3.21) | |
| Oct 17, 2024 | 2024 (Q3) | -4.62-2.93 | -9.14 | 67.99% (+6.21) | |
| Jul 18, 2024 | 2024 (Q2) | -5.32-6.31 | -9.16 | 31.11% (+2.85) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
